Cargando…
Humoral Response to SARS-Cov-2 Vaccination in Liver Transplant Recipients–A Single-Center Experience
Vaccination against SARS-CoV-2 infection is currently approved and shows favorable outcomes, but little known about antibody responses in solid organ transplant recipients, since these patients are known to have an impaired immune response upon vaccination and have not been included in admission stu...
Autores principales: | Rashidi-Alavijeh, Jassin, Frey, Alexandra, Passenberg, Moritz, Korth, Johannes, Zmudzinski, Jaqueline, Anastasiou, Olympia E., Saner, Fuat H., Jahn, Michael, Lange, Christian M., Willuweit, Katharina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310292/ https://www.ncbi.nlm.nih.gov/pubmed/34358154 http://dx.doi.org/10.3390/vaccines9070738 |
Ejemplares similares
-
Durability of Immune Response after Application of a Third Dose of SARS-CoV-2 Vaccination in Liver Transplant Recipients
por: Passenberg, Moritz, et al.
Publicado: (2023) -
Patients with Liver Cirrhosis Show High Immunogenicity upon COVID-19 Vaccination but Develop Premature Deterioration of Antibody Titers
por: Willuweit, Katharina, et al.
Publicado: (2022) -
Transplantation for Primary Sclerosing Cholangitis: Outcomes and Recurrence
por: Saner, Fuat H., et al.
Publicado: (2023) -
Standard coagulation tests are superior to thromboelastometry in predicting outcome of patients with liver cirrhosis
por: Rashidi-Alavijeh, Jassin, et al.
Publicado: (2020) -
Real-World Administration of Once-Daily MeltDose(®) Prolonged-Release Tacrolimus (LCPT) Allows for Dose Reduction of Tacrolimus and Stabilizes Graft Function Following Liver Transplantation
por: Willuweit, Katharina, et al.
Publicado: (2020)